Conference Calendar - The 33rd International Papillomavirus Conference

Times are stated in CEST (GMT + 2 / UTC + 2)
Every effort has been made to convert the IPVC 2020 scientific program into a fully virtual program. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive program on the virtual conference platform. Please note that some presenters were not able to pre-record their presentations, therefore there are still some sessions with missing presentations.

To view the pre-conference workshops, you need to register for them separately. Please contact: reg_ipvc20@kenes.com
You will then receive an email with instructions on how to login to the workshops’ platform.

Displaying One Session

View

Public Health Oral Session

00860 - Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination (ID 48)

Session Type

Public Health Oral Session

Session Date

07/23/2020

Session Time

08:30 - 09:55

Room

Hall E

Chair(s)

Watch Stream
Session Webcast

Session Webcast

[{"name":"MULTI-COHORT HPV VACCINATION ENABLES CERVICAL CANCER ELIMINATION DURING THIS CENTURY FOR REGIONS WITH HIGH HIV PREVALENCE \u003Csmall\u003E(ID 1041)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1041,"presentation":"MULTI-COHORT HPV VACCINATION ENABLES CERVICAL CANCER ELIMINATION DURING THIS CENTURY FOR REGIONS WITH HIGH HIV PREVALENCE \u003Csmall\u003E(ID 1041)\u003C\/small\u003E","session":"Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination","presenter":"Cara Bayer (United States of America)","photo":""},"playlist":[{"name":"MULTI-COHORT HPV VACCINATION ENABLES CERVICAL CANCER ELIMINATION DURING THIS CENTURY FOR REGIONS WIT","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/P1041_S1060_Cara Bayer.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/48\/P1041_S1060_Cara Bayer.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/2579FC8D.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/P1041_S1060_Cara Bayer.vtt"}]},{"name":"BUDGET OPTIMISATION STRATEGY TOWARDS ELIMINATION OF CERVICAL CANCER UNDER AGEING, URBANISATION AND SEXUAL OPENING TRANSITION SETTINGS FROM 2015 TO 2100 IN CHINA: A MODELLING STUDY \u003Csmall\u003E(ID 227)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":227,"presentation":"BUDGET OPTIMISATION STRATEGY TOWARDS ELIMINATION OF CERVICAL CANCER UNDER AGEING, URBANISATION AND SEXUAL OPENING TRANSITION SETTINGS FROM 2015 TO 2100 IN CHINA: A MODELLING STUDY \u003Csmall\u003E(ID 227)\u003C\/small\u003E","session":"Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination","presenter":"Changfa Xia (China)","photo":""},"playlist":[{"name":"BUDGET OPTIMISATION STRATEGY TOWARDS ELIMINATION OF CERVICAL CANCER UNDER AGEING, URBANISATION AND S","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/P227_S1060_BUDGET OPTIMISATION STRATEGY.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/48\/P227_S1060_BUDGET OPTIMISATION STRATEGY.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/9D61AB94.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/P227_S1060_BUDGET OPTIMISATION STRATEGY.vtt"}]},{"name":"COST-EFFECTIVENESS OF CERVICAL CANCER ELIMINATION IN LOW- AND MIDDLE-INCOME COUNTRIES (LMICS): EXAMPLE FROM VIETNAM \u003Csmall\u003E(ID 819)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":819,"presentation":"COST-EFFECTIVENESS OF CERVICAL CANCER ELIMINATION IN LOW- AND MIDDLE-INCOME COUNTRIES (LMICS): EXAMPLE FROM VIETNAM \u003Csmall\u003E(ID 819)\u003C\/small\u003E","session":"Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination","presenter":"Diep Thi Ngoc Nguyen (Australia)","photo":""},"playlist":[{"name":"COST-EFFECTIVENESS OF CERVICAL CANCER ELIMINATION IN LOW- AND MIDDLE-INCOME COUNTRIES (LMICS): EXAMP","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/819 Diep Thi Ngoc.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/48\/819 Diep Thi Ngoc.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/ED538045.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/819 Diep Thi Ngoc.vtt"}]},{"name":"COST-EFFECTIVENESS OF COMMUNITY HEALTH CAMPAIGN STRATEGIES TO DELIVER SELF-COLLECTED HUMAN PAPILLOMAVIRUS-BASED TESTING FOR CERVICAL CANCER SCREENING IN KENYA \u003Csmall\u003E(ID 271)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":271,"presentation":"COST-EFFECTIVENESS OF COMMUNITY HEALTH CAMPAIGN STRATEGIES TO DELIVER SELF-COLLECTED HUMAN PAPILLOMAVIRUS-BASED TESTING FOR CERVICAL CANCER SCREENING IN KENYA \u003Csmall\u003E(ID 271)\u003C\/small\u003E","session":"Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination","presenter":"Jessica Y. Islam (United States of America)","photo":""},"playlist":[{"name":"Jessica Islam - IPVC20 - 271","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/Jessica Islam - IPVC20 - 271.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/48\/Jessica Islam - IPVC20 - 271.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/74ABFCB.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/Jessica Islam - IPVC20 - 271.vtt"}]},{"name":"ACCEPTABLE UNIT PRICE DIFFERENCES BETWEEN HPV VACCINES FOR SEX-NEUTRAL VACCINATION ARE LOWER THAN FOR GIRLS-ONLY \u003Csmall\u003E(ID 921)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":921,"presentation":"ACCEPTABLE UNIT PRICE DIFFERENCES BETWEEN HPV VACCINES FOR SEX-NEUTRAL VACCINATION ARE LOWER THAN FOR GIRLS-ONLY \u003Csmall\u003E(ID 921)\u003C\/small\u003E","session":"Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination","presenter":"Simopekka V\u00e4nsk\u00e4 (Finland)","photo":""},"playlist":[{"name":"ACCEPTABLE UNIT PRICE DIFFERENCES BETWEEN HPV VACCINES FOR SEX-NEUTRAL VACCINATION ARE LOWER THAN FO","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/Simopekka V\u00e4nsk\u00e4 - IPVC20 - 921 - ACCEPTABLE UNIT PRICE DIFFERENCES BETWEEN HPV VACCINES FOR SEX-NEUTRAL VACCINATION ARE LOWER THAN FOR GIRLS-ONLY_new.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/48\/Simopekka V\u00e4nsk\u00e4 - IPVC20 - 921 - ACCEPTABLE UNIT PRICE DIFFERENCES BETWEEN HPV VACCINES FOR SEX-NEUTRAL VACCINATION ARE LOWER THAN FOR GIRLS-ONLY_new.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/3FDAFED9.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/Simopekka V\u00e4nsk\u00e4 - IPVC20 - 921 - ACCEPTABLE UNIT PRICE DIFFERENCES BETWEEN HPV VACCINES FOR SEX-NEUTRAL VACCINATION ARE LOWER THAN FOR GIRLS-ONLY_new.vtt"}]},{"name":"CATCH-UP VACCINATION HAS GREATER INCREMENTAL IMPACT ON CERVICAL CANCER INCIDENCE IN HIGH VS. MEDIUM HIV BURDEN SETTING \u003Csmall\u003E(ID 1060)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1060,"presentation":"CATCH-UP VACCINATION HAS GREATER INCREMENTAL IMPACT ON CERVICAL CANCER INCIDENCE IN HIGH VS. MEDIUM HIV BURDEN SETTING \u003Csmall\u003E(ID 1060)\u003C\/small\u003E","session":"Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination","presenter":"Gui Liu (United States of America)","photo":""},"playlist":[{"name":"CATCH-UP VACCINATION HAS GREATER INCREMENTAL IMPACT ON CERVICAL CANCER INCIDENCE IN HIGH VS. MEDIUM ","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/GMT20200624-044837_Gui-Liu-IP_1760x900-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/48\/GMT20200624-044837_Gui-Liu-IP_1760x900-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/3AFE5097.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/48\/GMT20200624-044837_Gui-Liu-IP_1760x900-0.vtt"}]}]

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination Hall E

MULTI-COHORT HPV VACCINATION ENABLES CERVICAL CANCER ELIMINATION DURING THIS CENTURY FOR REGIONS WITH HIGH HIV PREVALENCE (ID 1041)

Session Date

07/23/2020

Session Time

08:30 - 09:55

Room

Hall E

Session Type

Public Health Oral Session

Session Name

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination

Lecture Time

08:30 - 08:42

Presenter

Cara Bayer (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination Hall E

EXPLAINING DIFFERENCES BETWEEN DYNAMIC HPV TRANSMISSION MODELS IN PREDICTING VACCINATION IMPACT: A MODEL COMPARISON STUDY (ID 454)

Session Date

07/23/2020

Session Time

08:30 - 09:55

Room

Hall E

Session Type

Public Health Oral Session

Session Name

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination

Lecture Time

08:42 - 08:54

Presenter

Jan Hontelez (Netherlands)

Authors

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination Hall E

BUDGET OPTIMISATION STRATEGY TOWARDS ELIMINATION OF CERVICAL CANCER UNDER AGEING, URBANISATION AND SEXUAL OPENING TRANSITION SETTINGS FROM 2015 TO 2100 IN CHINA: A MODELLING STUDY (ID 227)

Session Date

07/23/2020

Session Time

08:30 - 09:55

Room

Hall E

Session Type

Public Health Oral Session

Session Name

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination

Lecture Time

08:54 - 09:06

Presenter

Changfa Xia (China)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination Hall E

COST-EFFECTIVENESS OF CERVICAL CANCER ELIMINATION IN LOW- AND MIDDLE-INCOME COUNTRIES (LMICS): EXAMPLE FROM VIETNAM (ID 819)

Session Date

07/23/2020

Session Time

08:30 - 09:55

Room

Hall E

Session Type

Public Health Oral Session

Session Name

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination

Lecture Time

09:06 - 09:18

Presenter

Diep Thi Ngoc Nguyen (Australia)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination Hall E

COST-EFFECTIVENESS OF COMMUNITY HEALTH CAMPAIGN STRATEGIES TO DELIVER SELF-COLLECTED HUMAN PAPILLOMAVIRUS-BASED TESTING FOR CERVICAL CANCER SCREENING IN KENYA (ID 271)

Session Date

07/23/2020

Session Time

08:30 - 09:55

Room

Hall E

Session Type

Public Health Oral Session

Session Name

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination

Lecture Time

09:18 - 09:30

Presenter

Jessica Y. Islam (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination Hall E

ACCEPTABLE UNIT PRICE DIFFERENCES BETWEEN HPV VACCINES FOR SEX-NEUTRAL VACCINATION ARE LOWER THAN FOR GIRLS-ONLY (ID 921)

Session Date

07/23/2020

Session Time

08:30 - 09:55

Room

Hall E

Session Type

Public Health Oral Session

Session Name

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination

Lecture Time

09:30 - 09:42

Presenter

Simopekka Vänskä (Finland)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination Hall E

CATCH-UP VACCINATION HAS GREATER INCREMENTAL IMPACT ON CERVICAL CANCER INCIDENCE IN HIGH VS. MEDIUM HIV BURDEN SETTING (ID 1060)

Session Date

07/23/2020

Session Time

08:30 - 09:55

Room

Hall E

Session Type

Public Health Oral Session

Session Name

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination

Lecture Time

09:42 - 09:54

Presenter

Gui Liu (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination Hall E

Online Chat Q&A for this session is called: PUBLIC HEALTH ORAL SESSION 11: MODELLING II. MODELLING AND ECONOMIC ANALYSES FOR CERVICAL CANCER ELIMINATION. You can join the online chat Q&A and discussions for this session by going back to the Lobby and entering the Networking Lounge. Speakers are encouraged to be online in the chat room at the time this session is stated to end. All times are in CEST. (ID 1809)

Session Date

07/23/2020

Session Time

08:30 - 09:55

Room

Hall E

Session Type

Public Health Oral Session

Session Name

Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination

Lecture Time

09:54 - 09:54